Holen Sie sich die Stockscreener-App
41.62
3.95%
-1.71
Vorhandelsmarkt:
42.30
0.68
+1.63%
Schlusskurs vom Vortag:
$43.33
Offen:
$42.25
24-Stunden-Volumen:
682.39K
Relative Volume:
0.48
Marktkapitalisierung:
$3.28B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-11.69%
1M Leistung:
-11.92%
6M Leistung:
-11.37%
1J Leistung:
+0.00%
1-Tages-Spanne:
$41.31
$42.53
1-Wochen-Bereich:
$41.31
$47.27
52-Wochen-Spanne:
$33.42
$62.18
Hinge Health Inc Stock (HNGE) Company Profile
Firmenname
Hinge Health Inc
Sektor
Branche
Telefon
415-689-8429
Adresse
455 MARKET STREET, SAN FRANCISCO
Vergleichen Sie HNGE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HNGE
Hinge Health Inc
|
41.62 | 3.41B | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
216.26 | 36.53B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
66.78 | 12.51B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
41.10 | 7.77B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
84.00 | 7.29B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
38.73 | 7.07B | 11.99B | 24.18M | 234.31M | 0.2956 |
Hinge Health Inc Stock (HNGE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | Wells Fargo | Overweight |
| 2025-09-05 | Eingeleitet | Robert W. Baird | Neutral |
| 2025-07-14 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-06-16 | Eingeleitet | Barclays | Overweight |
| 2025-06-16 | Eingeleitet | BofA Securities | Buy |
| 2025-06-16 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-06-16 | Eingeleitet | Evercore ISI | Outperform |
| 2025-06-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2025-06-16 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-06-16 | Eingeleitet | Needham | Buy |
| 2025-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2025-06-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-06-16 | Eingeleitet | Raymond James | Outperform |
| 2025-06-16 | Eingeleitet | Stifel | Buy |
| 2025-06-16 | Eingeleitet | Truist | Buy |
| 2025-06-16 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Hinge Health Inc Aktie (HNGE) Neueste Nachrichten
Hinge Health Inc (HNGE) Trading Down 3.2% on Jan 20 - GuruFocus
Stifel reiterates Buy rating on Hinge Health stock citing MSK care gaps - Investing.com
Will Hinge Health Inc. (HNGE) beat estimates again in its next earnings report? - MSN
Assessing Hinge Health (HNGE) Valuation As Shares Show Recent Uptick But Weak Broader Momentum - Yahoo Finance
Hinge Health’s 2026 State of Musculoskeletal Care Report reveals stark gaps in traditional care - Business Wire
Hinge Health (NYSE:HNGE) Trading Down 7.8%Here's What Happened - MarketBeat
Will Hinge Health Inc. (HNGE) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Hinge Health to announce fourth quarter and full year 2025 financial results on February 10, 2026 - FinancialContent
Hinge Health: Strong Usage Momentum, Conservative Growth Expectations, and Competitive Moat Support Buy Rating - TipRanks
Hinge Health (NYSE:HNGE) Upgraded at Wells Fargo & Company - MarketBeat
Piper Sandler lowers Hinge Health stock price target to $60 from $71 - Investing.com Canada
Piper Sandler lowers Hinge Health stock price target to $60 from $71 By Investing.com - Investing.com South Africa
Hinge Health, Inc. Class A Common Stock (NY: HNGE - FinancialContent
HNGE Stock Coverage Initiated by Wells Fargo with Overweight Rat - GuruFocus
Hinge Health stock initiated with Overweight rating by Wells Fargo - Investing.com Australia
What earnings margins imply for Hinge Health Inc. Class stockPrice Action & Comprehensive Market Scan Insights - ulpravda.ru
Hinge Health announces $250M buyback program - MSN
Contact UsConcord Monitor - FinancialContent
Hinge Health (NYSE:HNGE) CEO Sells $7,729,922.70 in Stock - MarketBeat
Hinge Health (HNGE) CEO & 10% owner logs 166,665-share conversion, stock sales - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Needham names Hinge Health stock as top health tech pick for 2026 - Investing.com Nigeria
Needham names Hinge Health stock as top health tech pick for 2026 By Investing.com - Investing.com South Africa
Hinge Health (NYSE:HNGE) Earns Buy Rating from Needham & Company LLC - MarketBeat
Needham on Hinge Health Inc (HNGE): 2026 Health Tech Top Pick - StreetInsider
HNGE shareholder (HNGE) plans Rule 144 stock sale and reports 10b5-1 trades - Stock Titan
Hinge Health (HNGE) president reports RSU tax withholding of 1,118 shares - Stock Titan
[Form 4] Hinge Health, Inc. Insider Trading Activity - Stock Titan
Notable Newcomers: These 2025 IPOs Dominated the Year - Investing.com
Hinge Health (HNGE) Maintains Overweight Rating, Price Target Lo - GuruFocus
Hinge Health joins Progyny for pelvic floor therapy - MSN
Hinge Health Earnings Notes - Trefis
Hinge Health, Inc. Class A Common Stock (NYSE:HNGE) Stock Quote - FinancialContent
Hinge Health (NYSE:HNGE) Shares Little Changed in Tech Sector - Kalkine Media
Hinge Health Inc. (NYSE:HNGE) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Hinge Health (NYSE:HNGE) Stock Rating Lowered by Wall Street Zen - MarketBeat
Hinge Health Inc. (NYSE:HNGE) Short Interest Update - MarketBeat
Hinge Health CFO Budge sells $507,836 in stock By Investing.com - Investing.com Nigeria
Hinge Health (NYSE:HNGE) President Sells $726,000.00 in Stock - MarketBeat
James Budge Sells 10,491 Shares of Hinge Health (NYSE:HNGE) Stock - MarketBeat
Hinge Health CFO Budge sells $507,836 in stock - Investing.com India
Hinge Health Executives Sell Shares Under Trading Plan - TradingView — Track All Markets
Hinge Health (HNGE) president reports 15,000-share Rule 10b5-1 sale - Stock Titan
Hinge Health (HNGE) CFO reports 10,491-share sale in planned trade - Stock Titan
HNGE (HNGE) shareholder details planned sale of 15,000 shares under Rule 144 - Stock Titan
[144] Hinge Health, Inc. SEC Filing - Stock Titan
Here is What Analysts Have to Say About Hinge Health (HNGE) - Finviz
Finanzdaten der Hinge Health Inc-Aktie (HNGE)
Es liegen keine Finanzdaten für Hinge Health Inc (HNGE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
7.99%
7.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):